References
Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor response to activated protein C. Proc Natl Acad Sci USA 1993; 90:1004.
Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, Ronde H de, Velden PA van der, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64.
Dahlback B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 1994; 24:139.
De Lucia D, De Blasio G, Belli A, et al. High prevalence of activated protein C resistance in patients with systemic sclerosis. Int J Clin Lab Res 1995; 25:226.
Halbmayer WM, Haushofer A, Schon R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis 1994; 5:51.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Lucia, D., d’Alessio, D., Pezzella, S. et al. A hypercoagulable state in activated protein C resistant patients with ischemic stroke. Int J Clin Lab Res 28, 74–75 (1998). https://doi.org/10.1007/BF02874085
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02874085